IL-22, whilst possessing both pro- and anti-inflammatory effects, can promote cancer cell growth and enhance chemoresistance [59], allowing infiltration of M2-like macrophages in adipose tissue, and driving a systemic anti-tumour effect [60]. Here, IL22 is linked to cancer.